Role of neuroprotective drugs in acute ischemic stroke

Cerebrovascular Diseases

Volumn 10, Issue SUPPL. 4, 2000, Pages 24-26

  Venti, Michele ^a   Parnetti, L ^a   Silvestrelli, G ^a   Gallai, V ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Neuroprotection; Stroke

Indexed keywords

6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CLOMETHIAZOLE; ELIPRODIL; GAVESTINEL; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LUBELUZOLE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; PIRACETAM; SCAVENGER; TIRILAZAD;

BRAIN ISCHEMIA; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; NEUROPROTECTION; PRIORITY JOURNAL;

EID: 0033772990     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047589     Document Type: Conference Paper

References (21)

1. Clinical trial update: Neuroprotection against acute ischaemic stroke
2. Cerebral protective effects of low grade hypothermia
3. Barbiturate protection in acute focal cerebral ischemia
4. Metaanalysis of oral nimodipine trials in acute ischemic stroke
5. VENUS Very Early Nimodipine Use in Stroke: Preliminary trial results
6. Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies
7. Clinical experience with excitatory amino acid antagonist drugs
8. Termination of Acute Stroke Study Involving Selfotel Treatment
9. Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke
10. Safety and tolerability of GV150526 in acute stroke
11. Cerestat and other NMDA antagonists in ischemic stroke
12. Does neuroprotection improve stroke outcome?
13. The Clomethiazole Acute Stroke Study Collaborative Group (CLASS)
14. Synergistic protective effects of antioxidant and nitric oxide synthase inhibitor in transient focal ischemia
15. High dose tirilazad for acute stroke (RAN-TASII)
16. Ebselen in acute ischemic stroke: A placebo-controlled, double-blind clinical trial
17. Acute treatment of stroke
18. Clinical trials with neuroprotective drugs in acute ischaemic stroke: Are we doing the right thing?
19. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways
20. Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): An open-label, dose escalation study in patients hospitalized for acute stroke
21. Neuroprotection as initial therapy in acute stroke